A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease
- PMID: 31135717
- DOI: 10.1097/MPH.0000000000001517
A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease
Abstract
The authors describe a newborn diagnosed with localized neuroblastoma that evolved to stage 4s at the age of 5 months. Peculiar features of the case included a bilateral adrenal primary, the skin as the only metastatic site, and the development of a muscular lesion late in the clinical course. The patient underwent left adrenalectomy and all other lesions regressed without further therapy. The case prompted a search for similar cases both in the Italian Neuroblastoma Registry and in the literature. All patients identified, although variously treated, survived with the exception of the 2 with MYCN gene amplification. We conclude that infants with neuroblastoma who undergo a transition from a localized to stage 4s disease could be less rare than expected. In the absence of unfavorable biology, a wait-and-see policy with strict follow-up could be adopted for these patients, avoiding potentially damaging systemic therapy.
References
-
- Luksch R, Castellani MR, Collini P, et al. Neuroblastoma (peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163–181.
-
- De Bernardi B, Mosseri V, Rubie H, et al. Treatment of localized resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer. 2008;99:1027–1033.
-
- Hero B, Simon T, Spitz R, et al. Localized infant neuroblastoma often shows spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008;26:1504–1510.
-
- Rubie H, De Bernardi B, Gerrard M, et al. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol. 2011;29:449–455.
-
- Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S disease neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Study Group. J Clin Oncol. 2000;18:477–486.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical